MENLO PARK, Calif.-Thursday, March 30th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- IncellDx, Inc. announces the release of their CE marked OncoTect iO® Lung Kit today, March 30, 2017, entering the immunotherapeutic diagnostic market in Europe and countries that accept the CE- mark and declaration of conformity to the European In Vitro Diagnostic Directive 98/79 EC for registration of in vitro diagnostic devices. The OncoTect iO® Lung Kit is a flow cytometry based assay that quantifies Programmed Death Ligand 1 (PD-L1) on both tumor cells and immune cell subtypes in non-small cell lung cancer (NSCLC) samples (fresh tissue or fine needle aspirates). This assay signals the launch of a new family of multi-parametric molecular products for immune-oncology applications.

The OncoTect iO® Lung assay can also be used in clinical research, pharmaceutical discovery, and trials for other malignancies expressing PD-L1, including bladder, head & neck, an ... Read more »